论文信息 - Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas - 字舞流文

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

P. Chevallier | P. Moreau | A. Moreau | C. Touzeau | B. Mahé | C. Bossard | P. Thomaré | T. Gastinne | S. le Gouill | T. Guillaume | P. Peterlin | P. Gallas | V. Dubruille | A. Lok | N. Blin | F. Perrin | B. Tessoulin | A. Garnier | E. Delande | J. Moynard | J. Boudreault